The U.S. Food and Drug Administration (FDA) has approved a drug called Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
FDA Warns Against Three “Sexual Enhancement” Supplements
Jun 20, 2019
The manufacturer of a supplement called The Beast has issued a voluntary recall of the product after the U.S. FDA discovered an erectile dysfunction (ED) drug among the ingredients.
Genetic Vitamin D Deficiency Associated with Low Testosterone
Jun 12, 2019
Men with genetic vitamin D deficiency could be at greater risk for low testosterone, according to a recent study in the Journal of Clinical Endocrinology & Metabolism.
